SCHEMBL13005693

SCHEMBL13005693

COc1c(CC(C)C)cccc1-c1cccc(C(=O)N[C@H](CN(C)C)c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.50
ROCK1 Q13464 3/20 0.50
UTS2R Q9UKP6 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061023 0.92 ROCK2 (0.51) ROCK2ROCK1UTS2R
SCHEMBL13005524 0.86 MME (0.43) ROCK2ROCK1
SCHEMBL13005496 0.86 MME (0.43) ROCK2ROCK1
SCHEMBL13005534 0.86 ROCK2 (0.40) ROCK2ROCK1UTS2R
SCHEMBL13005536 0.86 ROCK2 (0.40) ROCK2ROCK1UTS2R
SCHEMBL13005481 0.85 CTSL (0.41) ROCK2ROCK1UTS2R
SCHEMBL13005472 0.85 CTSL (0.41) ROCK2ROCK1UTS2R
SCHEMBL13005647 0.85 TAS1R3 (0.43) UTS2R
SCHEMBL13005652 0.85 TAS1R3 (0.43) UTS2R
SCHEMBL13005620 0.83 ROCK2 (0.38) ROCK2ROCK1UTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed